Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2013 | 8 | 4 | 455-462

Article title

Social functioning and support of addicts on methadone


Title variants

Languages of publication



The study aimed to determine characteristics of addicts on methadone maintenance therapy (MMT), which are related to the level of social functioning, with emphasis on the role of social support. In a prospective study, opiate addicts (n=150) who were on MMT completed the Pompidou questionnaire, the Social Adaptation Self-evaluation Scale (SASS) and the Multidimensional Scale of Perceived Social Support (MSPSS). Statistical data processing was based on testing the difference between features that best distinguish subgroups of addicts who were dissatisfied, moderately satisfied and satisfied with their social functioning. Opiate addicts up to 30 years of age had a statistically higher score on SASS scale than addicts over 30; addicts who are dissatisfied are mainly unemployed and have average or above-average family/community financial status; opiate addicts who were moderately satisfied with their social functioning were three years or longer on MMT; paradoxically, the highest mean value of score on MSPSS scale dominated among addicts who are dissatisfied with their social functioning. These results indicate that age, employment, financial status, duration of MMT are the characteristics of addicts which are related to the level of social functioning. Social support is most perceived by addicts who are dissatisfied with their social functioning.










Physical description


1 - 8 - 2013
12 - 6 - 2013


  • Institute of Public Health of Vojvodina, Novi Sad, Serbia


  • [1] Mattick R.P., Breen C., Kimber J., Davoli M., Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence, Cochrane Database of Systematic Reviews, 2009, 3, CD002209
  • [2] Keen J., Oliver P., Rowse G., Mathers N., Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?, Br J Gen Pract, 2003, 53, 461–467
  • [3] Corsi K.F., Lehman W.K., Booth R.E., The effect of methadone maintenance on positive outcomes for opiate injection drug users, J Subst Abuse Treat, 2009, 37, 120–6 http://dx.doi.org/10.1016/j.jsat.2008.11.004[Crossref]
  • [4] Joseph H., Stancliff S., Langrod J., Methadone maintenance treatment (MMT): a review of historical and clinical issues, Mt Sinai J Med, 2000, 67, 347–64
  • [5] Marsch L.A., The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis, Addiction, 1998, 93, 515–32 http://dx.doi.org/10.1046/j.1360-0443.1998.9345157.x[Crossref]
  • [6] Gunne L.M., Gronbladh L., The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend, 1981, 7, 249–256 http://dx.doi.org/10.1016/0376-8716(81)90096-X[Crossref]
  • [7] Ball J.C., Lange W.R., Myers C.P., Friedman S.R., Reducing the risk of AIDS through methadone maintenance treatment, J Health Soc Behav., 1988, 30, 673–684
  • [8] Poser W., Koc J., Ehrenreich H., Methadone maintenance treatment. Methadone treatment can reduce mortality, BMJ, 1995, 310, 463 http://dx.doi.org/10.1136/bmj.310.6977.463a[Crossref]
  • [9] Padaiga Z., Subata E., Vanagas G., Outpatient methadone maintenance treatment program. QoL and health of opioid-dependent persons in Lithuania, Medicina (Kaunas), 2007, 43, 235–41
  • [10] Maeyer J., Vanderplasschen W., Lammertyn J., Nieuwenhuizen C., Sabbe B., Broekaert E., Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment, Qual Life Res, 2011, 20, 139–150 http://dx.doi.org/10.1007/s11136-010-9732-3[Crossref]
  • [11] Wiklund I., Assessment of patient-reported outcomes in clinical trials: The example of health-related quality of life, Fundamental and Clinical Pharmacology, 2004, 18, 351–363 http://dx.doi.org/10.1111/j.1472-8206.2004.00234.x[Crossref]
  • [12] Millson P.E., Challacombe L., Villeneuve P.J., Strike C.J., Fischer B., Myers T., et al., Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs, European Addiction Research, 2006, 12, 74–82 http://dx.doi.org/10.1159/000090426[Crossref]
  • [13] Lofwall M.R., Brooner R.K., Bigelow G.E., Kindbom K., Strain E.C., Characteristics of older opioid maintenance patients, Journal of Substance Abuse Treatment, 2005,28,265–272 http://dx.doi.org/10.1016/j.jsat.2005.01.007[Crossref]
  • [14] Deering D.E., Frampton M.A., Horn J., Sellman J.D., Adamson S.J., Potiki T.L., Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire, Drug and Alcohol Review, 2004, 23, 273–280 http://dx.doi.org/10.1080/09595230412331289428[Crossref]
  • [15] Haug N.A., Sorensen J.L., Lollo N.D., Gruber V.A., Delucchi K.L., Hall S.M., Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial, AIDS Care, 2005, 17, 1022–1029 http://dx.doi.org/10.1080/09540120500100882[Crossref]
  • [16] Astals M., Domingo-Salvany A., Buenaventura C.C., Tato J., Vazquez J.M., Martin-Santos R., et al., Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment, Substance Use and Misuse, 2008, 43, 612–632 http://dx.doi.org/10.1080/10826080701204813[Crossref]
  • [17] Preau M., Protopopescu C., Spire B., Sobel A., Dellamonica P., Moatti J.P., et al., Health related quality of life among both current and former injection drug users who are HIV-infected, Drug and Alcohol Dependence, 2007, 86, 175–182 http://dx.doi.org/10.1016/j.drugalcdep.2006.06.012[Crossref]
  • [18] Maeyer J., Vanderplasschen W., Broekaert E., Exploratory study on drug users’ perspectives on quality of life: More than health-related quality of life?, Social Indicators Research, 2009, 90, 107–126 http://dx.doi.org/10.1007/s11205-008-9315-7[Crossref]
  • [19] Brands B., Brands J., Methadone Maintenance: A Physician’s Guide to Treatment. Toronto: Addiction Research Foundation, Centre for Addiction and Mental Health, 1998
  • [20] Vuckovic N., Dickov A., Martinovc-Mitrovic S., Budisa D., Drugs and medicine. Novi Sad: Futura; 2009, (in Serbian)
  • [21] Bosc M., Dubini A., Polin V., Development and validation of a social functioning scale, the Social Adaptation Self-Evaluation Scale, Eur Neuropsychopharmacol, 1997, 7, S57–S70 http://dx.doi.org/10.1016/S0924-977X(97)00420-3[Crossref]
  • [22] Zimet G.D., Dahlem N.W., Zimet S.G., Farley G.K., The multidimensional scale of perceived social support, Journal of Personality Assessment, 1988, 52, 30–41 http://dx.doi.org/10.1207/s15327752jpa5201_2[Crossref]
  • [23] Seivewright N.A., Greenwood J., What is important in drug misuse treatment?, Lancet, 1996, 347, 373–376 http://dx.doi.org/10.1016/S0140-6736(96)90542-5[Crossref]
  • [24] European Monitoring Centre for Drugs and drug Addiction, Annual report on the state of the drugs problems in the European Union, Office for Official Publications of the European Communities, Luxembourg, 2001
  • [25] Ward J., Hall W., Mattick R.P., Role of maintenance treatment in opioid dependence, Lancet, 1999, 353, 221–226 http://dx.doi.org/10.1016/S0140-6736(98)05356-2[Crossref]
  • [26] Ogborne A.C., Patient characteristics as predictors of treatment outcome for alcohol and drug abusers, In: Israel Y., Glaser F.B., Kalant H., Popham R.E., Schmidt W., Smart R.G, (Eds.) Research Advances in Alcohol and Drug Abuse, New York, Plenum Press, 1978, 177–366 http://dx.doi.org/10.1007/978-1-4615-7734-8_5[Crossref]
  • [27] TOPPS-II Interstate Cooperative Study Group, Drug treatment completion and post-discharge employment in the TOPPS-II Interstate Cooperative Study, Journal of Substance Abuse Treatment, 2003, 25, 9–18 http://dx.doi.org/10.1016/S0740-5472(03)00050-3[Crossref]
  • [28] Magura S., Staines G.L., Blankertz L., Madison E.M., The effectiveness of vocational services for substance users in treatment, Substance Use and Misuse, 2004, 39, 2165–2213 http://dx.doi.org/10.1081/JA-200034589[Crossref]
  • [29] Mino A., Page D., Dumont P., Broers B., Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva, Drug and Alcohol Dependence, 1998, 50, 233–239 http://dx.doi.org/10.1016/S0376-8716(98)00035-0[Crossref]
  • [30] Henry-Edwards S., et al., Clinical Guidelines and Procedures for the Use of Methadone in the Maintenance Treatment of Opioid Dependence, National Drug Strategy, Australian Government Department of Health and Ageing, 2003
  • [31] Van de Velde J.C., Schaap G.E., Land H., Followup at a Dutch addiction hospital and the effectiveness of therapeutic community treatment, Substance Use and Misuse, 1998, 33, 1611–1627 http://dx.doi.org/10.3109/10826089809058947[Crossref]
  • [32] Gossop M., Marsden J., Stewart D., Rolfe A., Treatment retention and 1 year outcomes for residential programmes in England, Drug and Alcohol Dependence, 1999, 57, 89–98 http://dx.doi.org/10.1016/S0376-8716(99)00086-1[Crossref]
  • [33] McMurphy S., Shea J., Switzer J., Turner B., Clinc-based treatment for opoid dependance: A qualitative inquiry, American Journal of Health Behavior, 2006, 30, 544–554 http://dx.doi.org/10.5993/AJHB.30.5.11[Crossref]
  • [34] Dawson D., Grant B., Stinson F., Chou P., Huang B., Ruan W.J., Recovery from DSM-IV alcohol dependence: United States, 2001–2002, Addiction, 2005,100, 281–292 http://dx.doi.org/10.1111/j.1360-0443.2004.00964.x[Crossref]
  • [35] McKellar J., Kelly J., Harris A., Moos R., Pretreatment and during treatment risk factors for dropout among patients with substance use disorders, Journal of Addictive Behaviors, 2006, 31, 450–460 http://dx.doi.org/10.1016/j.addbeh.2005.05.024[Crossref]
  • [36] Moos R., Moos B., Sixteen-year changes and stable remission among treated and untreated individuals with alcohol use disorders, Drug and Alcohol Dependence, 2005, 80, 337–347 http://dx.doi.org/10.1016/j.drugalcdep.2005.05.001[Crossref]
  • [37] Schutte K., Nichols K., Brennan P., Moos R., A tenyear follow-up of older former problem drinkers: Risk of relapse and implications of successfully sustained remission, Journal of Studies on Alcohol, 2003, 64, 367–374
  • [38] Booth B., Russell D., Soucek S., Laughlin P., Social support and alcoholism treatment: An exploratory analysis, American Journal of Alcohol Abuse, 1992, 18, 87–101 http://dx.doi.org/10.3109/00952999209001614[Crossref]
  • [39] Broome K., Simpson D., Joe G., The role of social support following short-term inpatient treatment, American Journal of Addictions, 2002, 11, 57–65 http://dx.doi.org/10.1080/10550490252801648[Crossref]
  • [40] Cohen S., Lichtenstein E., Partner behaviors that support quitting smoking, Journal of Consulting and Clinical Psychology, 1990, 58, 304–302 http://dx.doi.org/10.1037/0022-006X.58.3.304[Crossref]
  • [41] Goehl L., Nunes E., Quitkin F., Hilton I., Social networks and methadone treatment outcomes: The costs and benefits of social ties, American Journal of Drug and Alcohol Abuse, 1993, 19, 251–262 http://dx.doi.org/10.3109/00952999309001617[Crossref]
  • [42] Havassy B., Hall S., Wasserman D., Social support and relapse: Commonalities among alcoholics, opiate users and cigarette smokers, Addictive Behaviors, 1991, 16, 232–246
  • [43] Kidorf M., King V., Neufeld K., Stoller K., Peirce J., Brooner R., Involving significant others in the case of opioid-dependent patients receiving methadone, Journal of Substance Abuse Treatment, 2005, 29, 19–27 http://dx.doi.org/10.1016/j.jsat.2005.03.006[Crossref]
  • [44] Wasserman D., Stewart A., Delucchi K., Social support and abstinence from opiates and cocaine during opioid maintenance treatment, Drug and Alcohol Dependence, 2001, 65, 65–75 http://dx.doi.org/10.1016/S0376-8716(01)00151-X[Crossref]
  • [45] Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M., Drug abuse treatment: a national study of effectiveness, Carey: University of North Carolina Press, 1989
  • [46] Simpson D.D., Sells SB., Effectiveness of treatment for drug abuse: an overview of the DARP research program, Advances in Alcohol and Substance Abuse, 1982, 2, 7–29 http://dx.doi.org/10.1300/J251v02n01_02[Crossref]
  • [47] McGlothlin W.H., Anglin M.D., Long-term follow-up of clients of high- and low-dose methadone programs, Arch Gen Psychiatry, 1981, 38, 1055–63 http://dx.doi.org/10.1001/archpsyc.1981.01780340107013[Crossref]
  • [48] Joe G.W., Simpson D.D., Hubbard R.L., Treatment predictors of tenure in methadone maintenance, J Subst Abuse, 1991, 3, 73–84 http://dx.doi.org/10.1016/S0899-3289(05)80007-0[Crossref]
  • [49] Magura S., Nwakeze P.C., Demsky S.Y., Pre- and in-treatment predictors of retention in methadone treatment using survival analysis, Addiction, 1998, 93, 51–60 http://dx.doi.org/10.1046/j.1360-0443.1998.931516.x[Crossref]
  • [50] Xiao L., Wu Z., Luo W., Wei X., Quality of Life of Outpatients in Methadone Maintenance Treatment Clinics, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 53, S116–S120 http://dx.doi.org/10.1097/QAI.0b013e3181c7dfb5[Crossref]
  • [51] Polunina A.G., Davydov D.M., Kozlov A.A., Brain Disintegration in Heroin Addicts: The Natural Course of the Disease and the Effects of Methadone Treatment, Heroin Addict Relat Clin Probl, 2007, 9, 17–26
  • [52] Magura S., Goldsmith D., Casriel C., Goldstein P.J., Lipton D., The validity of methadone clients’ self-reported drug use, International Journal of Addictions, 1987, 22, 727–749

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.